← Scroll for more →
Veracyte, Inc. (VCYT)
Services-Medical Laboratories
Latest Price
$50.28
TTM P/E
35.91
Normalized P/E
1990.25
TTM Div Yield
--
Fwd Div Yield
--
Book Value
17.40
P/B Ratio
2.89
Valuation metrics
adjust assumptions →EPS: $0.82
Book value / share: $16.50
Formula: √(22.5 × EPS × BVPS)
Graham Number
$17.45
65% downside
Base FCF: $64M (median of recent 5yr)
Growth: 25%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$64.41
+28% upside
EPS: $0.82
Target P/E: 36×
Formula: EPS × P/E
P/E Fair Value
$29.52
41% downside
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 13.49M | $792.0M | 16.78% | +313.8K | 2026-06-30 |
| FMR LLC | 7.70M | $452.0M | 9.58% | -61.1K | 2026-06-30 |
| Artisan Partners Limited Partnership | 5.54M | $325.0M | 6.89% | +42.0K | 2026-06-30 |
| Vanguard Portfolio Management LLC | 4.72M | $276.0M | 5.87% | +271.5K | 2026-06-30 |
| State Street Corp | 4.70M | $275.0M | 5.85% | -345.5K | 2026-06-30 |
| Vanguard Capital Management LLC | 3.59M | $211.0M | 4.47% | +61.7K | 2026-06-30 |
| Dimensional Fund Advisors LP | 2.83M | $166.0M | 3.52% | -54.6K | 2026-06-30 |
| First Trust Advisors LP | 2.51M | $147.0M | 3.12% | +390.9K | 2026-06-30 |
| ARK Investment Management LLC | 2.30M | $134.0M | 2.86% | -757.9K | 2026-06-30 |
| Wellington Management Group LLP | 2.27M | $133.0M | 2.83% | -284.1K | 2026-06-30 |